This compound is a sulfonylpyrrole derivative featuring a fluorophenyl group and a pyridine ring. It is primarily used as a pharmaceutical intermediate in research and manufacturing processes.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2170020-79-6
1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutane-1-carboxylic acid
Pharmaceutical intermediate for apalutamide metabolite
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Trilaciclib Impurity 3
Pharmaceutical impurity reference standard
N-Nitroso VonopraZan
Nitrosamine impurity reference standard
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
Pharmaceutical intermediate
Vonoprazan
active pharmaceutical ingredient
Vonoprazan Fumarate
potassium-competitive acid blocker
2-[[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]methyl-methylamino]butanedioic acid
IUYCRYCADFVWDK-UHFFFAOYSA-N
CN(CC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3)C(CC(=O)O)C(=O)O